Selected Publications

Boyd M, Cunningham SH, Brown MM, Mairs RJ and Wheldon TE (1999) Noradrenaline transporter gene transfer for radiation cell kill by [131I]meta-iodobenzylguanidine. GeneTherapy 6: 1147-1152

Carlin S, Cunningham SH, Boyd M, McCluskey A and Mairs RJ (2000). Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both 2 and 3 dimensional models. Cancer Gene Therapy 7: 1529-1536

Boyd M, Mairs RJ, SH Cunningham, SC Mairs, K Stevenson, A McCluskey, S Carlin, MM Brown, A Livingstone, L Wilson, and TE Wheldon (2000). A gene therapy/targeted radiotherapy strategy for radiation cell kill by [131I]meta-iodobenzylguanidine (2001). J Gene Medicine 3: 165-172

Cunningham SH, Boyd M, Brown MM, S Carlin, A McCluskey, A Livingstone, Mairs RJ and Wheldon TE (2000). Gene therapy approach to enhance the targeted radiotherapy of neuroblastoma. Med Ped Oncol 35: 708-711

Boyd M, Mairs RJ, Mairs SC, Livingstone A, SH Cunningham, Lesley Wilson1, 3, A McCluskey, Brown MM, Carlin S and Keith N (2001). Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill. Oncogene 20: 7804-7808.